1st April 2021
News
Freak chemistry accident turns Sygnature’s Senior VP – Alliance Management into legendary werewolf
25th March 2021
DMPK in vivo pharmacology News
Three of UK’s top drug discovery CROs join forces under the name Sygnature Discovery
18th February 2021
Drug Discovery News
Sygnature Creates Second Integrated Drug Discovery Site at Alderley Park
10th February 2021
Blog Events News
Sygnature & Altasciences join forces for new webinar series
5th February 2021
Awards News
Sygnature Discovery named Company of the Year at Bionow Annual Awards
21st January 2021
Computational Sciences Drug Discovery News
Sygnature Discovery Adopts OpenEye’s Orion™ Platform to Strengthen Molecular Design Services
19th January 2021
Awards News
Sygnature Discovery shortlisted for BioNow Company of the Year Award
18th January 2021
Bioscience News
Sygnature upgrades western blotting capability with Jess instrument from Protein Simple
8th January 2021
News
Dr Paul Overton becomes Chief Commercial Officer (CCO) at Sygnature
16th December 2020
Bioscience News Translational Sciences
£3M investment to expand high-throughput screening and translational oncology capabilities
10th December 2020
News
What happened? A 2020 Recap!
9th October 2020
Awards News
Sygnature Discovery wins Medilink Outstanding Achievement Award